GENFIT Reports First Half-Year 2023 Financial Results a

GENFIT Reports First Half-Year 2023 Financial Results and Provides Corporate Update

GENFIT Reports First Half-Year 2023 Financial Results and Provides Corporate Update

streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

France , Switzerland , United Kingdom , United States , Paris , France General , Seal Rock , Massachusetts , Cambridge , Cambridgeshire , Zurich , Züsz , French , Sandra Silvestri , Pascal Prigent , Steven Hildemann , Tom Huijbers , Sakina Sayah Jeanne , Uncertainties Of The Company , Cash Flow Of The Group , Phepatology Communications , Transition Services Agreement , Research As , Board Of Directors The Company , Company Annual Shareholder Meeting , Patient Affairs , Drug Administration , European Medicines Agency , Research Tax Credit , Us Securities Exchange Commission , Financiers French Financial Markets Authority , Nasdaq , Research Translational Science , Head Of Global Medical Affairs , Service Transition Agreement , International Financial Reporting Standards , Group Cash , Exchange Commission , Celloram Inc , Euronext , Chronic Liver Failure , Investigational New Drug , Digestive Disease Week , Seal Rock Therapeutics , Reactive Oxygen Species , Hepatic Encephalopathy , Urea Cycle Disorders , Organic Acidemias , Inborn Errors , Non Invasive Test , Annual Shareholder Meeting , Executive Vice President , Chief Medical Officer , Global Medical Affairs , Patient Safety , Executive Vice President Research , Translational Science , European Medicines , Orphan Drug Designation , License Agreement , Transition Services , Consolidated Statement , Year Business , Financial Report , Registration Document , French Autorit , Des March , Consolidated Financial Results , Condensed Consolidated Statements , Financial Position , Cash Flow , Half Year Business , Cash Flows , Primary Biliary Cholangitis , Nasdaq Global Select Market , Private Securities Litigation Reform Act , French Financial Markets Authority ,